Hu (DECEASED), Changdeng

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Inhibition of a Protein-Protein Interaction as a Potential Cancer Treatment
2022-HU-69918
  1. Pharmaceuticals
  2. Medical/Health
Hu (DECEASED), Changdeng
Method for Detection of Transiently Interacting Proteins
66261
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Tao, Weiguo Andy

Details

Dr. Chang-Deng Hu is a Professor of Medicinal Chemistry and Molecular Pharmacology. He received an M.D. from Bengbu Medical College, China, an M.S. in Cancer Immunology from Tongji Medical University, China, and a Ph.D. in Molecular Biology from Kobe University, Japan. Dr. Hu's research focuses on developing novel anti-cancer agents for cancer treatment, including using molecular, cellular, biochemical, genetic, and imaging approaches to study how cancer cell behaviors are regulated at the transcription and epigenetic levels.

For more information, visit Dr. Hu's Purdue website: https://www.mcmp.purdue.edu/faculty/hu1
or his Hu Lab website: http://people.pharmacy.purdue.edu/~hu1/